Related Experiment Video
Updated: Apr 27, 2026

Microfluidics in Assessing Platelet Function
Published on: November 8, 2024
Platelet-activating factors are associated with cognitive deficits in depressed coronary artery disease patients: a
Graham Mazereeuw, Nathan Herrmann, Hongbin Xu
1Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, 2075 Bayview Avenue, Room FG08, Toronto, ON M4N 3M5, Canada. Krista.Lanctot@sunnybrook.ca.
Insights
Certain platelet-activating factors (PAFs) are linked to cognitive decline in coronary artery disease (CAD) patients, especially those with depression. Specific PAFs correlate with poorer cognitive performance, while one may offer a protective effect.
Area of Science:
- Lipidomics
- Neuroscience
- Cardiology
Background:
- Coronary artery disease (CAD) patients face heightened risk of cognitive decline, particularly when experiencing major depression.
- Inflammatory processes, common in CAD and depression, are implicated in neurodegeneration and cognitive impairment.
- Platelet-activating factors (PAFs) are emerging as critical lipid mediators potentially linking inflammation, neurodegeneration, and cognitive decline in CAD.
Purpose of the Study:
- To investigate the association between various platelet-activating factors (PAFs) and cognitive performance in patients with coronary artery disease (CAD).
- To explore these relationships further in a subgroup of CAD patients with major depression.
Main Methods:
- Cross-sectional study involving 24 CAD patients (70.8% male, mean age 60.3 years).
- Cognitive performance assessed using a standardized battery, with global cognitive performance derived from summary z scores.
- Plasma PAF levels analyzed using electrospray ionization mass spectrometry (precursor ion scan).
Main Results:
- Elevated PAF PC(O-18:0/2:0) abundance correlated with poorer global cognitive performance in CAD patients (r=-0.45, P=0.03).
- In the major depressed subgroup, PAF PC(O-18:0/2:0), PC(O-16:0/2:0), and lyso-PAF PC(O-16:0/0:0) were associated with poorer cognitive performance.
- Higher PAF PC(O-19:5/2:0) levels were linked to better global cognitive performance, suggesting a potential compensatory role.
Conclusions:
- Specific PAFs show associations with global cognitive performance in CAD patients.
- These associations appear stronger in CAD patients with major depression.
- Further research is needed to confirm these preliminary findings and elucidate the role of PAFs in cognitive decline within this population.
Background:
Patients with coronary artery disease (CAD) are at risk of accelerated cognitive decline, particularly those with major depression. Mechanisms for cognitive deficits associated with CAD, and the effects of depression, remain poorly understood. However, CAD is associated with inflammatory processes that have been linked to neurodegeneration, may contribute to cognitive decline, and are elevated in depression. Platelet-activating factors (PAFs) are emerging as key lipid mediators that may be central to those processes and highly relevant to cognitive decline in CAD.
Methods:
This cross-sectional study investigated relationships between various PAFs and cognitive performance in 24 patients with CAD (age, 60.3 ± 9.4; 70.8% male). Analyses were repeated in a subgroup of 15 patients with CAD with major depression (DSM-IV). Cognitive performance was assessed using a standardized battery and summary z scores were calculated based on age, sex, and education norms. Global cognitive performance was the average of domain-specific z scores. Plasma PAF analyses were performed using electrospray ionization mass spectrometry (precursor ion scan).
Results:
A greater abundance of PAF PC(O-18:0/2:0) was associated with poorer global cognitive performance in patients with CAD (r=-0.45, P=0.03). In the major depressed subgroup, PAF PC(O-18:0/2:0) (r=-0.59, P=0.02) as well as PC(O-16:0/2:0) (r=-0.52, P=0.04), and lyso-PAF PC(O-16:0/0:0) (r=-0.53, P=0.04) were associated with poorer global cognitive performance. A greater abundance of PAF PC(O-19:5/2:0) was associated with better global cognitive performance (r=0.55, P=0.03), suggesting a possible compensatory species.
Conclusions:
This study suggests that certain PAFs might be associated with global cognitive performance in patients with CAD, with stronger relationships observed in those with major depression. Confirmation of these preliminary findings is warranted.
Related Concept Videos
Coronary Artery Disease II: Pathophysiology
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Formation of the Platelet Plug
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Cognitive Therapy
Acute Coronary Syndrome III: Diagnostic Studies

